ProBioGen Announces Further Development Milestone for Use of Its GlymaxX® Cancer Cell-Killing Enhancement Antibody Technology with Merus N.V.

Merus Initiates a Phase 1 Clinical Trial of MCLA-158, a Bispecific Antibody Utilizing ADCC-enhancing GlymaxX® Technology

More

Embryonic development: How do limbs develop from cells?

New microscopy software enables precise monitoring of cells

More

Early Warning for Epidemics - The challenge to solve

 

The challenge is to develop a scalable, reliable, and cost-effective early-warning system prototype to forecast and monitor vector-borne diseases in order to contribute to the prevention of outbreaks, mitigating their impact on local, regional and...

More

Startup Track 2018

 

At the World Health Summit, around 2,000 stakeholders and decision-makers from 100 countries and every field in the healthcare spectrum will work together to find solutions for global health challenges. As the world’s foremost strategic forum for...

More

NOXXON TO PRESENT CLINICAL TRIAL UPDATE AT BIO€QUITY EUROPE

Update highlights patient recruitment and effects of NOX-A12 monotherapy on the tumor microenvironment of a pancreatic tumor

More

3D structure of DNA forms defined room for dissociated lncRNAs to activate gene expression

Enhancers are regulatory regions of the DNA, giving rise to “long non-coding RNAs” (lncRNAs), which are known as crucial regulators of gene expression. Scientists from the Max Planck Institute for Molecular Genetics in Berlin now have shown that a...

More

ProBioGen signs Second Contract Development Agreement with Tizona Therapeutics for Immuno-Oncology Antibody Project

ProBioGen AG, a premier service & technology provider for complex therapeutic glycoproteins, today announced that it has signed a second clinical immuno-oncology development and manufacturing agreement with Tizona Therapeutics, Inc., a privately held...

More

Grants4Apps Global Dealmaker 2018

Take this unique opportunity to acquire Bayer as a customer

More

Revolutionary milk analysis platform allows for multiplex analysis of 100 antibiotic residues and toxins in a single test

Unisensor produces the lateral flow biosticks for its unique Extenso platform with SCIENION’s unrivalled sciFLEXARRAYER ultra-low volume dispensers

More
Show more items